San Diego, CA - December 20, 2001
LA JOLLA PHARMACEUTICAL TO PRESENT AT J.P. MORGAN H&Q HEALTHCARE CONFERENCE

San Diego, CA - November 28, 2001
LA JOLLA PHARMACEUTICAL'S LUPUS DRUG CANDIDATE RECEIVES EUROPEAN ORPHAN DRUG DESIGNATION

San Diego, CA - November 19, 2001
LA JOLLA PHARMACEUTICAL TO PRESENT AT ROBERTSON STEPHENS MEDICAL CONFERENCE

San Francisco, CA - November 14, 2001
DATA ON LA JOLLA PHARMACEUTICAL'S LUPUS DRUG PRESENTED AT ACR SHOWS SIMILAR REDUCTIONS IN DISEASE-CAUSING ANTIBODIES WHEN COMPARED TO IMMUNOSUPPRESSIVE DRUGS

San Diego, CA - November 8, 2001
LA JOLLA PHARMACEUTICAL BEGINS PHASE I/II CLINICAL TRIAL IN PATIENTS WITH ANTIBODY-MEDIATED THROMBOSIS

San Diego, CA - November 7, 2001
LA JOLLA PHARMACEUTICAL COMPANY
REPORTS THIRD QUARTER 2001 FINANCIAL RESULTS

San Diego, CA - October 24, 2001
LA JOLLA PHARMACEUTICAL TO PRESENT AT SALOMON SMITH BARNEY HEALTHCARE CONFERENCE

San Francisco, CA - October 16, 2001
DATA ON LA JOLLA PHARMACEUTICAL'S LUPUS DRUG PRESENTED AT WORLD CONGRESS OF NEPHROLOGY

San Diego, CA - October 3, 2001
LA JOLLA PHARMACEUTICAL TO PRESENT AT UBS WARBURG CONFERENCE

San Diego, CA - September 11, 2001
LA JOLLA PHARMACEUTICAL FILES IND TO BEGIN CLINICAL TESTING OF DRUG CANDIDATE FOR ANTIBODY-MEDIATED STROKE AND DEEP-VEIN THROMBOSIS

San Diego, CA - September 6, 2001
LUPUS MEDICAL JOURNAL HIGHLIGHTS
LA JOLLA PHARMACEUTICAL'S LEAD DRUG CANDIDATE

San Diego, CA - August 9, 2001
PHARMACEUTICAL COMPANY REPORTS SECOND QUARTER 2001 FINANCIAL RESULTS

San Diego, CA - August 8, 2001
LA JOLLA PHARMACEUTICAL ANNOUNCES PUBLICATION IN KEY THROMBOSIS MEDICAL JOURNAL

San Diego, CA - July 11, 2001
LA JOLLA PHARMACEUTICAL PRESENTS DATA ON STROKE DRUG AT INTERNATIONAL THROMBOSIS AND HAEMOSTASIS MEETING

San Diego, CA - July 10, 2001
LA JOLLA PHARMACEUTICAL ADDED TO RUSSELL 3000¨ INDEX

San Diego, CA - June 27, 2001
COUNTRY MUSIC LEGEND NAOMI JUDD AND OTHER PATIENT ADVOCATES SPEAK OUT AT BIO 2001

San Diego, CA - June 26, 2001
LA JOLLA PHARMACEUTICAL TO PRESENT AT INTERNATIONAL BIOTECHNOLOGY CONVENTION CEO to speak at patient advocacy outreach panel

San Diego, CA - June 13, 2001
FORMER ELI LILLY DIVISIONAL PRESIDENT JOINS THE BOARD OF LA JOLLA PHARMACEUTICAL COMPANY

San Diego, CA - June 11, 2001
LA JOLLA PHARMACEUTICAL'S PHASE III TRIAL EXPANDS TO EUROPE

San Diego, CA - May 15, 2001
LA JOLLA PHARMACEUTICAL APPOINTS VICE PRESIDENT OF MARKETING

San Diego, CA - May 10, 2001
LA JOLLA PHARMACEUTICAL RECEIVES PATENT ON NEW APPROACH TO STROKE TREATMENT

San Diego, CA - May 8, 2001
LA JOLLA PHARMACEUTICAL COMPANY REPORTS FIRST QUARTER 2001 FINANCIAL RESULTS

San Diego, CA - April 11, 2001
THREE MEDICAL JOURNALS PUBLISH PAPERS ON LA JOLLA PHARMACEUTICAL'S LUPUS DRUG CANDIDATE

San Diego, CA - March 29,2001
THE LUPUS FOUNDATION OF AMERICA AND LA JOLLA PHARMACEUTICAL COMPANY TEAM UP TO WARN OF HIDDEN SYMPTOMS OF LUPUS

Barcelona, Spain - March 28, 2001
DOSE DEPENDENT RESPONSE REPORTED BY LA JOLLA PHARMACEUTICAL AT INTERNATIONAL LUPUS CONFERENCE

San Diego, CA - February 26, 2001
LA JOLLA PHARMACEUTICAL COMPANY REPORTS FOURTH QUARTER 2000 FINANCIAL RESULTS

San Diego, CA - February 15, 2001
LA JOLLA PHARMACEUTICAL'S THROMBOSIS CANDIDATE REDUCED CLOTTING DEFECT IN ANIMAL MODEL OF DISEASE

San Diego, CA - February 6, 2001
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES $35.3 MILLION PRIVATE PLACEMENT

San Francisco - January 11, 2001
LA JOLLA PHARMACEUTICAL ANNOUNCES THAT IN THREE CLINICAL TRIALS 90% OF LUPUS PATIENTS HAVE KEY ANTIBODIES

San Francisco - January 10, 2001
BIACORE'S SPR TECHNOLOGY TO PLAY CRITICAL ROLE IN LA JOLLA PHARMACEUTICAL'S PHASE III TRIAL OF LUPUS THERAPEUTIC

San Diego, CA - January 9, 2001
LA JOLLA PHARMACEUTICAL TO PRESENT AT THE 19TH ANNUAL JP MORGAN H&Q HEALTHCARE CONFERENCE